The forced oscillation technique (FOT) using the flexiVent has been the gold standard for pulmonary function tests (PFTs) in small animal in vivo studies for many years2,3. These FOT measurements provide detailed measurements of airway constriction using small amplitude oscillations. Common allergic models apply bronchoconstrictor challengers or bronchodilator challenges in isolation to investigate the severity of the disease. By adding an inhaled bronchodilator during a bronchoconstrictor challenge, the effectiveness of the recovery agent can be tested in a novel preclinical method. The study was validated by using a bronchodilator immediately prior to a bronchoconstrictor dose in mice using the flexiVent for aerosol delivery of both compounds and assessing allergic airway hyperresponsiveness.
Balb/C mice were challenged with three 100µg house-dust mite extract instillations in the two weeks prior to measurements. Two days following the HDM instillations, mice were tracheostomized and connected to the flexiVent. The study ran four concentrations of methacholine (0, 10, 30, and 100mg/ml), and each was immediately preceded by either a saline or albuterol aerosol administration (0.083% in saline). The aerosol generation ran for ten seconds for both the albuterol/saline and the methacholine exposure at a duty cycle of 50%.
Airway mechanics were measured during the dose response, including the maximum using the flexiVent FX. The parameters measured were the total respiratory system resistance (Rrs), total respiratory system elastance (Ers), Newtonian resistance (Rn), tissue dampening (G), elastance (H) and airway hyperresponsiveness.
With the albuterol treated groups, their subjects saw significant attenuation of overall resistance, conducting airway resistance and tissue dampening, all indices of airway inflammation. The albuterol treatment also significantly blunted the overall lung stiffness. The tissue stiffness was reduced with the albuterol treatment, although not significantly.
Addison et al.’s study was able to demonstrate a method of testing the protective effects of bronchodilators in a traditional bronchoconstrictor study with the flexiVent system, a common measurement in allergic airway hyperresponsive models. As bronchoconstriction leads to wheezing and shortness of breath in asthmatic patients, testing bronchodilators protective effects on airway constriction is an important tool for the development of novel therapeutics.
Welcome to SCIREQ’s knowledge center. You can find everything from software registration to document downloads to complete list of SCIREQ publications in this section. Everything you need to get the most out of your SCIREQ system.
Please fill out the below form and a specialist will contact you as soon as possible